Abstract is: Stephen Jacob Chanock (born April 15, 1956) is an American physician and geneticist. He currently serves as Director of the Division of Cancer Epidemiology and Genetics at the U.S. National Cancer Institute (NCI).
| human | Q5 |
| P2671 | Google Knowledge Graph ID | /g/11c1rstdsp |
| P2798 | Loop ID | 32374 |
| P496 | ORCID iD | 0000-0002-2324-3393 |
| P69 | educated at | Princeton University | Q21578 |
| Harvard Medical School | Q49121 | ||
| P735 | given name | Stephen | Q4927100 |
| Stephen | Q4927100 | ||
| P106 | occupation | researcher | Q1650915 |
| geneticist | Q3126128 | ||
| P21 | sex or gender | male | Q6581097 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q115009414 | 1284-P: Genetic and Lifestyle Associations with Cardiometabolic Traits and Diabetes Risk Factors in Ethnically Diverse Africans |
| Q35836419 | 3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans |
| Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
| Q36029709 | A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma |
| Q42754133 | A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma |
| Q94683498 | A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry |
| Q50061836 | A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy. |
| Q55210146 | A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. |
| Q40597341 | A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci |
| Q53283615 | A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics. |
| Q56994856 | A Putative Exonic Splicing Polymorphism in the BCL6 Gene and the Risk of Non-Hodgkin Lymphoma |
| Q92515702 | A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer |
| Q57306192 | A candidate gene approach to searching for low-penetrance breast and prostate cancer genes |
| Q53577672 | A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. |
| Q46378338 | A common 8q24 variant in prostate and breast cancer from a large nested case-control study |
| Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
| Q44963243 | A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma |
| Q34528399 | A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q34459794 | A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer |
| Q45305326 | A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. |
| Q35605845 | A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q34211808 | A comprehensive examination of breast cancer risk loci in African American women |
| Q37475652 | A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33. |
| Q34353049 | A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry |
| Q34155993 | A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiency |
| Q33903385 | A fast and accurate method to detect allelic genomic imbalances underlying mosaic rearrangements using SNP array data |
| Q35093501 | A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer |
| Q34350941 | A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation |
| Q33747778 | A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. |
| Q35747147 | A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23 |
| Q28303909 | A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer |
| Q28943522 | A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus |
| Q33335147 | A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation |
| Q24597370 | A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 |
| Q28943348 | A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3 |
| Q37109758 | A genome-wide association study of breast cancer in women of African ancestry |
| Q36682471 | A genome-wide association study of early menopause and the combined impact of identified variants |
| Q29417036 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. |
| Q24657797 | A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma |
| Q34881099 | A genome-wide association study of marginal zone lymphoma shows association to the HLA region |
| Q33780746 | A genome-wide association study of prognosis in breast cancer |
| Q37705188 | A genome-wide association study of prostate cancer in West African men |
| Q37514659 | A genome-wide association study of renal cell carcinoma among African Americans |
| Q35177444 | A genome-wide pleiotropy scan for prostate cancer risk |
| Q34611972 | A genome-wide scan for breast cancer risk haplotypes among African American women |
| Q35925225 | A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences |
| Q34113217 | A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q24619411 | A large-scale candidate gene association study of age at menarche and age at natural menopause |
| Q34403997 | A mechanistic basis for amplification differences between samples and between genome regions |
| Q30416161 | A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry |
| Q35248192 | A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q92626990 | A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry |
| Q36477652 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease |
| Q37229749 | A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide |
| Q40628904 | A multi-locus genetic association test for a dichotomous trait and its secondary phenotype. |
| Q28943367 | A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci |
| Q112727841 | A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer |
| Q34085748 | A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). |
| Q38616258 | A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q33577138 | A new statistic and its power to infer membership in a genome-wide association study using genotype frequencies |
| Q46949960 | A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk |
| Q35660939 | A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk |
| Q37090435 | A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma |
| Q36969852 | A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma |
| Q37091594 | A report of cytokine polymorphisms and COPD risk in Xuan Wei, China |
| Q36745638 | A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk |
| Q34162606 | A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma |
| Q34414220 | A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background |
| Q30913791 | A spectrum of severe familial liver disorders associate with telomerase mutations |
| Q84698019 | A step toward slaying the hydra of second cancers |
| Q24169696 | A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits |
| Q83474482 | A twist on admixture mapping |
| Q47896712 | A two-platform design for next generation genome-wide association studies |
| Q24648667 | A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis |
| Q36327057 | ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium |
| Q37131928 | ABO blood group and the risk of pancreatic cancer |
| Q59196342 | Abstract 287: Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue |
| Q58074718 | Abstract 4593: Genome-wide association study identifies novel loci associated with osteosarcoma |
| Q58047207 | Abstract 4831: Additive and multiplicative gene-environment interactions for colorectal cancer risk |
| Q59059958 | Abstract 5071: A genome-wide association study suggests evidence of variants at 6p21.32 associated with marginal zone lymphoma |
| Q59060123 | Abstract 5072: Meta-analysis of genome-wide association studies identifies novel susceptibility loci for follicular lymphoma |
| Q58074642 | Abstract 5574: High prevalence of germline TP53 mutations in young osteosarcoma cases |
| Q57319487 | Abstract 942: Imputation from The 1000 Genomes Project identifies rare large effect variants of BRCA2-K3326X and CHEK2-I157T as risk factors for lung cancer; a study from the TRICL consortium |
| Q61948762 | Abstract LB-448: Genome-wide association study identifies new prostate cancer susceptibility loci |
| Q34472668 | Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium |
| Q34990595 | Advantage of using allele-specific copy numbers when testing for association in regions with common copy number variants |
| Q56333953 | Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age |
| Q37484995 | Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue |
| Q64989893 | Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. |
| Q34993331 | Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan) |
| Q42655897 | All the World's a Stage: Facilitating Discovery Science and Improved Cancer Care through the Global Alliance for Genomics and Health |
| Q112716496 | Altered regulation of DPF3, a member of the SWI/SNF complexes, underlies the 14q24 renal cancer susceptibility locus |
| Q37170192 | An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population |
| Q81318250 | An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3' haplotypes could modify circulating levels of mannose-binding lectin |
| Q33482168 | An analysis of growth, differentiation and apoptosis genes with risk of renal cancer |
| Q39551156 | An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer |
| Q46949065 | An unusual suspect: an uncommon human-specific synonymous coding variant within the UGT1A6 gene explains a GWAS signal and protects against bladder cancer |
| Q33503237 | Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk |
| Q30825136 | Analysis of chemotherapeutic response in ovarian cancers using publicly available high-throughput data |
| Q40185670 | Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma |
| Q24170413 | Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types |
| Q33750087 | Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis |
| Q34059780 | Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). |
| Q37474966 | Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk |
| Q35623603 | Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions |
| Q35082606 | Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk |
| Q45016568 | Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk |
| Q36020720 | Assessing disease risk in genome-wide association studies using family history |
| Q29616285 | Assessing the probability that a positive report is false: an approach for molecular epidemiology studies |
| Q35593347 | Assessment of copy number variation using the Illumina Infinium 1M SNP-array: a comparison of methodological approaches in the Spanish Bladder Cancer/EPICURO study |
| Q28740496 | Assessment of interactions between PAH exposure and genetic polymorphisms on PAH-DNA adducts in African American, Dominican, and Caucasian mothers and newborns |
| Q97070156 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q29547208 | Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index |
| Q57305944 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q36123803 | Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses |
| Q27851709 | Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer |
| Q40406762 | Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations |
| Q23910819 | Association between adult height, genetic susceptibility and risk of glioma |
| Q38794059 | Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast |
| Q44190089 | Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes |
| Q24626427 | Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity |
| Q33981705 | Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin |
| Q37200998 | Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study |
| Q92121129 | Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth |
| Q34914663 | Association of COMT haplotypes and breast cancer risk in caucasian women |
| Q37217468 | Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women |
| Q37659350 | Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study |
| Q33261851 | Association of MTHFR gene polymorphisms with breast cancer survival |
| Q35246178 | Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants |
| Q79834894 | Association of breast cancer outcome with status of p53 and MDM2 SNP309 |
| Q36191018 | Association of breast cancer risk loci with breast cancer survival |
| Q82337224 | Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis |
| Q37415242 | Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families |
| Q58047445 | Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q52576610 | Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. |
| Q34314362 | Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium |
| Q24630954 | Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations |
| Q57665241 | Associations of Classic Kaposi Sarcoma with Common Variants in Genes that Modulate Host Immunity |
| Q91045562 | Associations of autozygosity with a broad range of human phenotypes |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q54965252 | Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma. |
| Q28083556 | Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci |
| Q36100579 | Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases |
| Q122967062 | Author Correction to: Endemic Burkitt lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility |
| Q63966080 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q64118820 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q60907509 | Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
| Q60933652 | BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2 |
| Q38045331 | Basic principles and laboratory analysis of genetic variation |
| Q58047301 | Beyond odds ratios — communicating disease risk based on genetic profiles |
| Q36916852 | Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes |
| Q35852637 | Body Mass Index Genetic Risk Score and Endometrial Cancer Risk |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
| Q39734134 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States |
| Q35562912 | Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study |
| Q34158093 | Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression |
| Q37059782 | Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses |
| Q33898168 | C-reactive protein and risk of lung cancer |
| Q33994241 | CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk |
| Q58317854 | COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population |
| Q46751148 | CYBB, an NADPH-oxidase gene: restricted diversity in humans and evidence for differential long-term purifying selection on transmembrane and cytosolic domains |
| Q44449983 | CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q33616702 | CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium |
| Q45282594 | CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma |
| Q36750746 | CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk |
| Q57611157 | Cancer Sequencing Gets a Little More Personal |
| Q36359653 | Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations |
| Q34976173 | Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women |
| Q24649888 | Candidate gene polymorphisms for ischemic stroke |
| Q36981342 | Caspase polymorphisms and genetic susceptibility to multiple myeloma |
| Q36481104 | Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer |
| Q37097417 | Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies |
| Q38716510 | Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues |
| Q33275323 | Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma. |
| Q42694762 | Characterization of breakpoint regions of large structural autosomal mosaic events |
| Q36030354 | Characterization of gene-environment interactions for colorectal cancer susceptibility loci |
| Q24169697 | Characterization of large structural genetic mosaicism in human autosome |
| Q39002074 | Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry |
| Q33842251 | Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. |
| Q33921139 | Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans |
| Q37696685 | Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue |
| Q34183548 | Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk |
| Q22122062 | Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite |
| Q89026452 | Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia |
| Q37323444 | Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium |
| Q57796257 | Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study |
| Q100513823 | Circulating adipokine concentrations and risk of five obesity-related cancers: a Mendelian randomization study |
| Q98905585 | Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses |
| Q40538977 | Circulating levels and promoter polymorphisms of interleukins-6 and 8 in pediatric cancer patients with fever and neutropenia. |
| Q33295448 | Cis sequence effects on gene expression |
| Q91854850 | Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer |
| Q96617300 | Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance |
| Q48336537 | Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q58277186 | Combined somatic mutation and copy number analysis in the survival of familial CLL |
| Q64458461 | Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma |
| Q33434511 | Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk |
| Q36944260 | Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer |
| Q33974823 | Common genetic variants and central adiposity among Asian-Indians |
| Q33525051 | Common genetic variants and risk for HPV persistence and progression to cervical cancer |
| Q38450080 | Common genetic variants and risk for non-Hodgkin lymphoma and adult T-cell lymphoma/leukemia in Jamaica |
| Q24630753 | Common genetic variants in candidate genes and risk of familial lymphoid malignancies |
| Q36139148 | Common genetic variants in epigenetic machinery genes and risk of upper gastrointestinal cancers |
| Q36089535 | Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer |
| Q34450872 | Common genetic variants in miR-1206 (8q24.2) and miR-612 (11q13.3) affect biogenesis of mature miRNA forms |
| Q35868793 | Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) |
| Q35731430 | Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk |
| Q36126685 | Common genetic variants in the 8q24 region and risk of papillary thyroid cancer |
| Q28396581 | Common genetic variants in the 9p21 region and their associations with multiple tumours |
| Q35882541 | Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk |
| Q35193949 | Common genetic variants related to genomic integrity and risk of papillary thyroid cancer |
| Q37325815 | Common genetic variation and human disease |
| Q40301486 | Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study |
| Q36468817 | Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis |
| Q46897498 | Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status |
| Q44577591 | Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer |
| Q37392961 | Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited |
| Q46957453 | Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors |
| Q33829174 | Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q36456966 | Common obesity-related genetic variants and papillary thyroid cancer risk |
| Q43967751 | Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patients |
| Q34631671 | Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer |
| Q34020753 | Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut |
| Q33947829 | Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q29417145 | Common variants at 19p13 are associated with susceptibility to ovarian cancer |
| Q34792833 | Common variants in ZNF365 are associated with both mammographic density and breast cancer risk |
| Q115209587 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes |
| Q51921838 | Common variants in genes that mediate immunity and risk of multiple myeloma. |
| Q36948924 | Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer |
| Q102369493 | Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits |
| Q24641880 | Common variants near MC4R are associated with fat mass, weight and risk of obesity |
| Q29028729 | Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma |
| Q37170656 | Common variants of FUT2 are associated with plasma vitamin B12 levels |
| Q35235259 | Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer |
| Q35904497 | Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer |
| Q28943459 | Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer |
| Q59060370 | Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer |
| Q23919640 | Common variation in genes related to innate immunity and risk of adult glioma |
| Q89496341 | Comparative Histopathologic Analysis of "Radiogenic" and "Sporadic" Papillary Thyroid Carcinoma: Patients Born Before and After the Chernobyl Accident |
| Q91636534 | Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study |
| Q42633800 | Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2. |
| Q52980715 | Comparison of yield and genotyping performance of multiple displacement amplification and OmniPlex whole genome amplified DNA generated from multiple DNA sources. |
| Q31025638 | Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead |
| Q24614574 | Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium |
| Q34622559 | Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). |
| Q39770549 | Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk |
| Q35409934 | Comprehensive evaluation of one-carbon metabolism pathway gene variants and renal cell cancer risk |
| Q35886598 | Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer |
| Q36852553 | Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers |
| Q37424455 | Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer |
| Q34380520 | Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q37155532 | Consortium analysis of 7 candidate SNPs for ovarian cancer |
| Q93121796 | Constituents of Household Air Pollution and Risk of Lung Cancer among Never-Smoking Women in Xuanwei and Fuyuan, China |
| Q37064640 | Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia |
| Q34862975 | Constitutional telomerase mutations are genetic risk factors for cirrhosis |
| Q46643459 | Correction: Genome-Wide Association Scan Meta-Analysis Identifies Three Loci Influencing Adiposity and Fat Distribution. |
| Q45946765 | Correction: Identification, Replication, and Fine-Mapping of Loci Associated with Adult Height in Individuals of African Ancestry. |
| Q42502463 | Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study |
| Q42732939 | Correction: vitamin d metabolic pathway genes and pancreatic cancer risk |
| Q39699530 | Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway |
| Q57565042 | Corrigendum re “Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma” [Eur Urol 2017;72:747–54] |
| Q50240714 | Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci. |
| Q33272303 | Corroboration of a familial chordoma locus on chromosome 7q and evidence of genetic heterogeneity using single nucleotide polymorphisms (SNPs). |
| Q28396029 | Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer |
| Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
| Q92510114 | Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans |
| Q101216461 | Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers |
| Q34096825 | Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia |
| Q92184158 | Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer |
| Q37890286 | Current status of genome-wide association studies in cancer |
| Q44971675 | Cyclin D1 splice variant and risk for non-Hodgkin lymphoma |
| Q34542117 | Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma |
| Q35848263 | Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma |
| Q37632303 | Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study |
| Q33608214 | DNA fingerprinting of the NCI-60 cell line panel |
| Q35020482 | DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas |
| Q48424021 | DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
| Q37157893 | Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents |
| Q34441746 | Defining the role of common variation in the genomic and biological architecture of adult human height |
| Q23916196 | Detectable clonal mosaicism and its relationship to aging and cancer |
| Q28385149 | Detectable clonal mosaicism from birth to old age and its relationship to cancer |
| Q28392522 | Detectable clonal mosaicism in the human genome |
| Q92237320 | Detectible mosaic truncating PPM1D mutations, age and breast cancer risk |
| Q78746884 | Detection of common cytokine and colony stimulating factor gene polymorphisms |
| Q33802545 | Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers |
| Q36487491 | Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium |
| Q33759681 | Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk |
| Q28646221 | Directional dominance on stature and cognition in diverse human populations |
| Q30252516 | Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium. |
| Q60472142 | Discovery of common and rare genetic risk variants for colorectal cancer |
| Q24813357 | Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers |
| Q35518379 | Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants |
| Q28473396 | Diversity in the glucose transporter-4 gene (SLC2A4) in humans reflects the action of natural selection along the old-world primates evolution |
| Q33824208 | ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study |
| Q28749307 | Effect of gene-environment Interactions on mental development in African American, Dominican, and Caucasian mothers and newborns |
| Q24816650 | Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance |
| Q59196456 | Effects of Electron-Beam Irradiation on Whole Genome Amplification |
| Q33906376 | Effects of electron-beam irradiation on buccal-cell DNA. |
| Q30350759 | Effects of natural selection on interpopulation divergence at polymorphic sites in human protein-coding Loci |
| Q35795078 | Efficient study design for next generation sequencing |
| Q34338886 | Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer |
| Q62583131 | Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis |
| Q100533854 | Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility |
| Q34778269 | Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study |
| Q30432415 | Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium |
| Q45073555 | Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data |
| Q42828438 | Erratum to: The UBC-40 Urothelial Bladder Cancer Cell Line Index: a genomic resource for functional studies. |
| Q42379879 | Erratum to: The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies |
| Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
| Q57319395 | Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer |
| Q57271291 | Erratum: Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer |
| Q33784483 | Estimating the heritability of colorectal cancer |
| Q37475917 | Estimation of absolute risk for prostate cancer using genetic markers and family history |
| Q36191121 | Estimation of effect size distribution from genome-wide association studies and implications for future discoveries |
| Q37003547 | Etiologic heterogeneity among non-Hodgkin lymphoma subtypes |
| Q33595844 | Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies |
| Q21144976 | Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot" |
| Q89856026 | Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial |
| Q53332557 | Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. |
| Q33873837 | Evaluation of polygenic risk scores for predicting breast and prostate cancer risk |
| Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| Q47714066 | Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q28396836 | Evolution of multiple cell clones over a 29-year period of a CLL patient |
| Q37107579 | Evolutionary dynamics of the human NADPH oxidase genes CYBB, CYBA, NCF2, and NCF4: functional implications |
| Q33584276 | Exome-wide association study of endometrial cancer in a multiethnic population |
| Q34576967 | Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis |
| Q33788125 | Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q36588857 | FTO genotype is associated with phenotypic variability of body mass index |
| Q34080597 | Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). |
| Q27908479 | Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome |
| Q96955461 | Field Study of the Possible Effect of Parental Irradiation on the Germline of Children Born to Cleanup Workers and Evacuees of the Chornobyl Accident |
| Q37164415 | Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility |
| Q34158088 | Fine mapping of 14q24.1 breast cancer susceptibility locus |
| Q35056055 | Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer |
| Q34975896 | Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q36856343 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression |
| Q55380382 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q35389444 | Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans |
| Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
| Q35097143 | Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
| Q46837278 | Folate metabolism genes, vegetable intake and renal cancer risk in central Europe |
| Q90455618 | Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma |
| Q58047395 | Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study |
| Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
| Q37085369 | Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41. |
| Q80152805 | Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q23924182 | Further confirmation of germline glioma risk variant rs78378222 in TP53 and its implication in tumor tissues via integrative analysis of TCGA data |
| Q24997437 | Future perspectives on molecular epidemiology |
| Q34520370 | GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis |
| Q46609200 | GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma |
| Q33875520 | GWAS follow-up study of esophageal squamous cell carcinoma identifies potential genetic loci associated with family history of upper gastrointestinal cancer |
| Q33584624 | GWAS is going to the dogs |
| Q38408978 | GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer |
| Q33886166 | GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma |
| Q36435017 | GWASdb v2: an update database for human genetic variants identified by genome-wide association studies |
| Q35630781 | GWASdb: a database for human genetic variants identified by genome-wide association studies |
| Q57060220 | Gene editing reveals the effect of thousands of variants in a key cancer gene |
| Q59070007 | Gene editing reveals the effect of thousands of variants in a key cancer gene |
| Q34406143 | Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci |
| Q36049397 | Gene-environment interactions on growth trajectories |
| Q24683761 | Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study |
| Q34716723 | Generalizability of established prostate cancer risk variants in men of African ancestry |
| Q40498334 | Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors |
| Q39200248 | Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma |
| Q57780598 | Genetic Variation in Base Excision Repair Genes and the Prevalence of Advanced Colorectal Adenoma |
| Q57568634 | Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk |
| Q33725471 | Genetic admixture and population substructure in Guanacaste Costa Rica |
| Q115209620 | Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus |
| Q36903719 | Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA. |
| Q36474994 | Genetic association studies in cancer: good, bad or no longer ugly? |
| Q79327317 | Genetic association studies: marking them well |
| Q37251803 | Genetic background comparison using distance-based regression, with applications in population stratification evaluation and adjustment |
| Q37351650 | Genetic basis for adverse events after smallpox vaccination |
| Q35137952 | Genetic contributions to the association between adult height and testicular germ cell tumors |
| Q24634163 | Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China |
| Q35999323 | Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study |
| Q35048269 | Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer |
| Q57661758 | Genetic evidence of assortative mating in humans |
| Q108609948 | Genetic insights into biological mechanisms governing human ovarian ageing |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q92588645 | Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes |
| Q46988889 | Genetic polymorphisms and benzene metabolism in humans exposed to a wide range of air concentrations |
| Q36622888 | Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma |
| Q57272105 | Genetic polymorphisms in alcohol metabolism, alcohol intake and the risk of stomach cancer in Warsaw, Poland |
| Q53349070 | Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. |
| Q52576203 | Genetic polymorphisms in folate metabolism and the risk of stomach cancer. |
| Q36088045 | Genetic polymorphisms in oxidative stress pathway genes and modification of BMI and risk of non-Hodgkin lymphoma |
| Q28383262 | Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers |
| Q53577804 | Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. |
| Q34588092 | Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma |
| Q33488319 | Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q37281843 | Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q91362827 | Genetic predisposition to mosaic Y chromosome loss in blood |
| Q61229415 | Genetic predisposition to mosaic Y chromosome loss in blood is associated with genomic instability in other tissues and susceptibility to non-haematological cancers |
| Q109117088 | Genetic regulation of nonsense-mediated decay underlies association with risk of severe COVID-19 |
| Q92265367 | Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations |
| Q35806601 | Genetic risk variants associated with in situ breast cancer |
| Q64117700 | Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the "endemic Burkitt Lymphoma belt" |
| Q22305005 | Genetic studies of body mass index yield new insights for obesity biology |
| Q34132750 | Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong |
| Q37156413 | Genetic susceptibility loci for breast cancer by estrogen receptor status |
| Q41544357 | Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations |
| Q24624419 | Genetic susceptibility to distinct bladder cancer subphenotypes |
| Q37419151 | Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia |
| Q36521749 | Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia |
| Q35742829 | Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations |
| Q36971932 | Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population |
| Q45991816 | Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide. |
| Q53591009 | Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. |
| Q34852402 | Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population |
| Q37381396 | Genetic variants in fas signaling pathway genes and risk of gastric cancer |
| Q37154134 | Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia |
| Q36814006 | Genetic variants in sex hormone metabolic pathway genes and risk of esophageal squamous cell carcinoma |
| Q44789708 | Genetic variants in the 8q24 locus and risk of testicular germ cell tumors |
| Q37701536 | Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer |
| Q35569570 | Genetic variation and hematology: single-nucleotide polymorphisms, haplotypes, and complex disease |
| Q48258199 | Genetic variation and hematopoietic stem cell transplantation: expansion of the paradigm |
| Q80224767 | Genetic variation and the assessment of risk in septic patients |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q57515011 | Genetic variation at the 8q24 locus confers risk to multiple myeloma |
| Q46750307 | Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women |
| Q34064240 | Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection |
| Q46825192 | Genetic variation in CYP17 and endometrial cancer risk |
| Q36003303 | Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma |
| Q34273265 | Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma |
| Q89629357 | Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study |
| Q35559023 | Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland |
| Q34038369 | Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis |
| Q53261993 | Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. |
| Q53334287 | Genetic variation in TP53 and risk of breast cancer in a population-based case control study. |
| Q34785970 | Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies |
| Q34434505 | Genetic variation in a4GnT in relation to Helicobacter pylori serology and gastric cancer risk |
| Q37271012 | Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies |
| Q48401327 | Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial |
| Q37359752 | Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk |
| Q33298581 | Genetic variation in five genes important in telomere biology and risk for breast cancer |
| Q46642326 | Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors |
| Q35142180 | Genetic variation in immune function and susceptibility to human filariasis |
| Q36360694 | Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk |
| Q28386043 | Genetic variation in metabolic genes, occupational solvent exposure, and risk of non-hodgkin lymphoma |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q37354850 | Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland |
| Q34657155 | Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma |
| Q33418117 | Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility |
| Q54604727 | Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia. |
| Q24811147 | Genetic variation in the HSD17B1 gene and risk of prostate cancer |
| Q33599595 | Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis |
| Q37454788 | Genetic variation in the androgen receptor gene and endometrial cancer risk |
| Q57568620 | Genetic variation in the base excision repair pathway and bladder cancer risk |
| Q34520415 | Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia |
| Q100528967 | Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort |
| Q34381577 | Genetic variation in the inhibin pathway and risk of testicular germ cell tumors |
| Q28287147 | Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery |
| Q36741744 | Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium |
| Q57272107 | Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF–LTA) and breast cancer risk |
| Q51937498 | Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. |
| Q28742817 | Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
| Q33221984 | Genetic variation, nucleotide diversity, and linkage disequilibrium in seven telomere stability genes suggest that these genes may be under constraint |
| Q82481455 | Genetic variations in CC chemokine receptors and hypertension |
| Q34203675 | Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer |
| Q89737463 | Genetically Determined Height and Risk of Non-hodgkin Lymphoma |
| Q28393571 | Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes |
| Q100939919 | Genetically predicted telomere length is associated with clonal somatic copy number alterations in peripheral leukocytes |
| Q98614008 | Genetics and Geography of Leukocyte Telomere Length in Sub-Saharan Africans |
| Q81334628 | Genewindow: an interactive tool for visualization of genomic variation |
| Q92612714 | Genome-Wide Association Study in Irradiated Childhood Cancer Survivors Identifies HTR2A for Subsequent Basal Cell Carcinoma |
| Q47601903 | Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q89467799 | Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia |
| Q34346358 | Genome-wide CNV analysis replicates the association between GSTM1 deletion and bladder cancer: a support for using continuous measurement from SNP-array data |
| Q36172361 | Genome-wide SNP typing reveals signatures of population history |
| Q37078854 | Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course |
| Q21092142 | Genome-wide and candidate gene association study of cigarette smoking behaviors |
| Q28943312 | Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions |
| Q28943345 | Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q37637724 | Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q93270780 | Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility |
| Q50674084 | Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. |
| Q21092459 | Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution |
| Q84307313 | Genome-wide association studies and "the art of the soluble" |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q24632585 | Genome-wide association studies identify loci associated with age at menarche and age at natural menopause |
| Q33814805 | Genome-wide association studies in cancer--current and future directions |
| Q53190358 | Genome-wide association studies in melanoma: off to a good start. |
| Q40346126 | Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer |
| Q57551327 | Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases |
| Q24289213 | Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases |
| Q28383750 | Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population |
| Q97530380 | Genome-wide association study data reveal genetic susceptibility to chronic inflammatory intestinal diseases and pancreatic ductal adenocarcinoma risk |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q29417135 | Genome-wide association study identifies a common variant associated with risk of endometrial cancer |
| Q35200169 | Genome-wide association study identifies common variants associated with circulating vitamin E levels |
| Q34288685 | Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region |
| Q28659283 | Genome-wide association study identifies multiple loci associated with bladder cancer risk |
| Q56346041 | Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility |
| Q28943339 | Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia |
| Q33804470 | Genome-wide association study identifies multiple risk loci for renal cell carcinoma |
| Q28248768 | Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma |
| Q34314018 | Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer |
| Q28924380 | Genome-wide association study identifies new prostate cancer susceptibility loci |
| Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
| Q46904091 | Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients |
| Q35892365 | Genome-wide association study identifies three common variants associated with serologic response to vitamin E supplementation in men |
| Q28659642 | Genome-wide association study identifies two susceptibility loci for osteosarcoma |
| Q24626464 | Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer |
| Q37045108 | Genome-wide association study of age at menarche in African-American women |
| Q34295620 | Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women |
| Q35532911 | Genome-wide association study of circulating retinol levels |
| Q33904451 | Genome-wide association study of circulating vitamin D levels |
| Q33614777 | Genome-wide association study of circulating vitamin D-binding protein |
| Q37140021 | Genome-wide association study of colorectal cancer identifies six new susceptibility loci |
| Q28660394 | Genome-wide association study of endometrial cancer in E2C2 |
| Q34033939 | Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. |
| Q41625456 | Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q23919638 | Genome-wide association study of glioma and meta-analysis |
| Q38873936 | Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors |
| Q29614925 | Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 |
| Q35009643 | Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. |
| Q38970751 | Genome-wide association study of prostate cancer-specific survival |
| Q37622580 | Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer |
| Q33900326 | Genome-wide association study of relative telomere length |
| Q28943264 | Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 |
| Q37002577 | Genome-wide association study of serum selenium concentrations |
| Q28943489 | Genome-wide association study of survival in patients with pancreatic adenocarcinoma |
| Q35615396 | Genome-wide association study of susceptibility loci for breast cancer in Sardinian population |
| Q37380035 | Genome-wide association study of tanning phenotype in a population of European ancestry |
| Q24646654 | Genome-wide association study reveals genetic risk underlying Parkinson's disease |
| Q29417001 | Genome-wide diet-gene interaction analyses for risk of colorectal cancer |
| Q96431376 | Genome-wide gene-diabetes and gene-obesity interaction scan in 8,255 cases and 11,900 controls from the PanScan and PanC4 Consortia |
| Q28943359 | Genome-wide interaction study of smoking and bladder cancer risk |
| Q36001590 | Genome-wide meta-analyses of smoking behaviors in African Americans |
| Q28943288 | Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture |
| Q49816011 | Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. |
| Q21144958 | Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption |
| Q28655044 | Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture |
| Q34321689 | Genome-wide search for gene-gene interactions in colorectal cancer |
| Q35002165 | Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway |
| Q37235560 | Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits |
| Q37012918 | Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study |
| Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
| Q38823212 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk |
| Q112716940 | Genomic and evolutionary classification of lung cancer in never smokers |
| Q36776604 | Genomic and functional analysis of the sodium-dependent vitamin C transporter SLC23A1-SVCT1. |
| Q37415174 | Genomic variation in a global village: report of the 10th annual Human Genome Variation Meeting 2008. |
| Q44471700 | Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations |
| Q33543396 | Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density |
| Q35860364 | Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies |
| Q58388066 | Germ-line genetic variation ofTP53 in osteosarcoma |
| Q40158003 | Germline Genetic Variants and Lung Cancer Survival in African Americans |
| Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
| Q36294747 | Germline TP53 variants and susceptibility to osteosarcoma. |
| Q58050324 | Germline determinants of the somatic mutation landscape in 2,642 cancer genomes |
| Q52716844 | Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma. |
| Q98775276 | Germline sequencing DNA repair genes in 5,545 men with aggressive and non-aggressive prostate cancer |
| Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
| Q58611475 | Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
| Q43525663 | Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study |
| Q46395048 | Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer |
| Q37412180 | HGV2009 meeting: bigger and better studies provide more answers and more questions |
| Q37401100 | HGV2011: personalized genomic medicine meets the incidentalome |
| Q36711371 | HGV2012: leveraging next-generation technology and large datasets to advance disease research |
| Q54465029 | HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes. |
| Q42602210 | HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies |
| Q34014453 | HSD17B1 genetic variants and hormone receptor-defined breast cancer |
| Q51802043 | Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. |
| Q46952791 | Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies |
| Q37484235 | Haplotypes of the estrogen receptor beta gene and breast cancer risk |
| Q34081904 | Hematotoxicity in workers exposed to low levels of benzene |
| Q58047443 | Hemochromatosis gene mutations and distal adenomatous colorectal polyps |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q81425125 | High level of functional polymorphism indicates a unique role of natural selection at human immune system loci |
| Q45952114 | High marks for GWAS. |
| Q30923933 | High-throughput single nucleotide polymorphism genotyping using nanofluidic Dynamic Arrays |
| Q36443875 | Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort |
| Q58378082 | Host Immunogenetics and Control of Human Herpesvirus–8 Infection |
| Q36915855 | Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era |
| Q50797392 | Human Genome Variation 2006: emerging views on structural variation and large-scale SNP analysis. |
| Q39289406 | Human genetics and respiratory syncytial virus disease: current findings and future approaches |
| Q36843558 | Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma |
| Q53202453 | Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. |
| Q35070838 | Human pharmacogenomic variations and their implications for antifungal efficacy |
| Q43899558 | Human variation 2.0: using GWAS to probe intermediate phenotypes |
| Q24630979 | Hundreds of variants clustered in genomic loci and biological pathways affect human height |
| Q33348545 | IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q34561553 | IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q37006170 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. |
| Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
| Q29417155 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array |
| Q30491274 | Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models |
| Q29416993 | Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis |
| Q36069872 | Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer |
| Q36198138 | Identification of a new prostate cancer susceptibility locus on chromosome 8q24. |
| Q34975918 | Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript |
| Q36754771 | Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36968428 | Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders |
| Q28390088 | Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues |
| Q37399647 | Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q41023668 | Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q58351997 | Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk |
| Q28275237 | Identification of ten loci associated with height highlights new biological pathways in human growth |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q31036626 | Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry |
| Q100568879 | Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects |
| Q61226938 | Immune gene expression profiling reveals heterogeneity in luminal breast tumors |
| Q92128706 | Immune gene expression profiling reveals heterogeneity in luminal breast tumors |
| Q53552236 | Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. |
| Q34464890 | Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians |
| Q34512941 | Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies |
| Q35129044 | Immunomodulation of invasive fungal infections |
| Q52655627 | Impact of atopy on risk of glioma: a Mendelian randomisation study. |
| Q35747559 | Improved imputation of common and uncommon SNPs with a new reference set. |
| Q23924183 | Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 |
| Q92488631 | Inappropriate Citation of Vaccine Article |
| Q110788180 | Incident disease associations with mosaic chromosomal alterations on autosomes, X and Y chromosomes: insights from a phenome-wide association study in the UK Biobank |
| Q45004211 | Inflammation-related gene polymorphisms and colorectal adenoma |
| Q34443672 | Inflammatory gene variants and the risk of biliary tract cancers and stones: a population-based study in China |
| Q40745717 | Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment. |
| Q35747554 | Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade |
| Q52659457 | Influence of obesity-related risk factors in the aetiology of glioma. |
| Q30519549 | Inherited genetic variation and overall survival following follicular lymphoma |
| Q90631958 | Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q35967379 | Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma |
| Q37262162 | Innate immunity gene polymorphisms and the risk of colorectal neoplasia |
| Q36706719 | Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma |
| Q55693698 | Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival. |
| Q36849912 | Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q33845203 | Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival |
| Q27310019 | Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer |
| Q36065460 | Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions |
| Q104070233 | Integrative molecular characterization of gallbladder cancer reveals microenvironment-associated subtypes |
| Q40071035 | Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium |
| Q35166701 | Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium |
| Q36077025 | Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate |
| Q41193948 | Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA). |
| Q57272128 | Interleukin-8 Polymorphisms Are Not Associated with Gastric Cancer Risk in a Polish Population |
| Q38873586 | International cancer seminars: a focus on kidney cancer |
| Q44815678 | Introduction: sifting through the characterization of hematologic malignancies |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q47428850 | Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer |
| Q28396727 | Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations |
| Q23921519 | Joint associations between genetic variants and reproductive factors in glioma risk among women |
| Q23917504 | Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk |
| Q23910347 | Known glioma risk loci are associated with glioma with a family history of brain tumours--a case-control gene association study |
| Q47317001 | LDassoc: an online tool for interactively exploring genome-wide association study results and prioritizing variants for functional investigation |
| Q36226921 | LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants |
| Q90380081 | LDlinkR: An R Package for Rapidly Calculating Linkage Disequilibrium Statistics in Diverse Populations |
| Q36618819 | LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era. |
| Q35022313 | LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer |
| Q37711685 | LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk |
| Q57565079 | La caractérisation fonctionnelle du locus de susceptibilité au cancer du rein 12p11.23 implique le gène SHARP1 |
| Q58047408 | Lack of Association of Transforming Growth Factor- 1 Polymorphisms and Haplotypes with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Trial |
| Q91006696 | Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis |
| Q35627634 | Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer |
| Q114823362 | Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accident |
| Q40226483 | Landscape of Combination Immunotherapy and Targeted Therapy to Improve Cancer Management |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q38730359 | Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes |
| Q37090402 | Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity |
| Q33275297 | Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk |
| Q53498780 | Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study. |
| Q34899553 | Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study |
| Q35119669 | Large-scale fine mapping of the HNF1B locus and prostate cancer risk |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q34125066 | Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background |
| Q26158530 | Lead exposure and glioma among rural residents: the Upper Midwest Health Study |
| Q51124795 | Leveraging family history in population-based case-control association studies. |
| Q34572467 | Leveraging population admixture to characterize the heritability of complex traits |
| Q30575708 | Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data |
| Q34494290 | Limited evidence that cancer susceptibility regions are preferential targets for somatic mutation |
| Q89929962 | Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study |
| Q43924342 | Loci associated with skin pigmentation identified in African populations. |
| Q34650906 | Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q98938934 | Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma |
| Q44929346 | Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. |
| Q46737936 | Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma |
| Q27486245 | MBL2and Hepatitis C Virus Infection among Injection Drug Users |
| Q57272133 | Mannose-binding lectin-2 genetic variation and stomach cancer risk |
| Q35856276 | Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer |
| Q96126621 | Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma |
| Q39923821 | Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations |
| Q63976782 | Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer |
| Q35815677 | Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk |
| Q56089167 | Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q48102990 | Mendelian randomisation study of the relationship between vitamin D and risk of glioma |
| Q98772941 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer |
| Q99616191 | Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk |
| Q34248904 | Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways |
| Q37046338 | Meta-analysis identifies four new loci associated with testicular germ cell tumor |
| Q40163628 | Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor. |
| Q36675182 | Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia |
| Q28385292 | Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women |
| Q35670184 | Meta-analysis of new genome-wide association studies of colorectal cancer risk |
| Q80293455 | Metabolic gene variants and risk of non-Hodgkin's lymphoma |
| Q30977635 | Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults |
| Q33612013 | Methods for detecting interactions between genetic polymorphisms and prenatal environment exposure with a mother-child design |
| Q35156802 | MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q44681221 | Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. |
| Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
| Q36361883 | Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms |
| Q79851992 | Modifiers of risk for infectious complications of cancer therapy in children: the long road ahead |
| Q28395222 | Mosaic 13q14 deletions in peripheral leukocytes of non-hematologic cancer cases and healthy controls |
| Q90227210 | Mosaic Y Loss Is Moderately Associated with Solid Tumor Risk |
| Q89777909 | Mosaic chromosome 20q deletions are more frequent in the aging population |
| Q40301119 | Mosaic chromosome Y loss and testicular germ cell tumor risk. |
| Q89930504 | Mosaic chromosome Y loss is associated with alterations in blood cell counts in UK Biobank men |
| Q28393244 | Mosaic loss of chromosome Y is associated with common variation near TCL1A |
| Q33960537 | Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome |
| Q35551949 | Multilevel-analysis identify a cis-expression quantitative trait locus associated with risk of renal cell carcinoma |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q28943507 | Multiple loci identified in a genome-wide association study of prostate cancer |
| Q39568294 | Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations |
| Q34347579 | Mutation of GATA3 in human breast tumors |
| Q24606163 | Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease |
| Q34409487 | Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia |
| Q24682080 | Mutations in the SBDS gene in acquired aplastic anemia |
| Q58388077 | Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure |
| Q73217622 | Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome |
| Q34603354 | NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses |
| Q34988026 | National Cancer Institute Prostate Cancer Genetics Workshop |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q42666413 | Next generation modeling in GWAS: comparing different genetic architectures. |
| Q37148030 | Nitric oxide synthase gene polymorphisms and prostate cancer risk |
| Q34057961 | No association between FTO or HHEX and endometrial cancer risk |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q37632955 | Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England |
| Q52998000 | Nonsynonymous SNPs: validation characteristics, derived allele frequency patterns, and suggestive evidence for natural selection. |
| Q56359054 | Novel Common Genetic Susceptibility Loci for Colorectal Cancer |
| Q34070675 | Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologists |
| Q39006292 | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study |
| Q59137307 | Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways |
| Q61840927 | Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways |
| Q53349076 | Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. |
| Q34354158 | Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study |
| Q36312968 | Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma |
| Q36095714 | Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma |
| Q34069062 | Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants |
| Q74308244 | One gene and one outcome? No way |
| Q37654985 | One thousand genomes imputation in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium aggressive prostate cancer genome-wide association study |
| Q34692324 | One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia |
| Q86308349 | Opportunities-and hard work-ahead |
| Q37116922 | Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma |
| Q90019249 | Origins, admixture dynamics and homogenization of the African gene pool in the Americas |
| Q52716449 | Outdoor air pollution and mosaic loss of chromosome Y in older men from the Cardiovascular Health Study. |
| Q35759885 | Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study |
| Q53366320 | Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q36440086 | PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium |
| Q24650256 | PTEN identified as important risk factor of chronic obstructive pulmonary disease |
| Q33705238 | PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q56089368 | Pancreatic Cancer Risk is Modulated by Inflammatory Potential of Diet and ABO Genotype: A Consortia-based Evaluation and Replication Study |
| Q34094983 | Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium |
| Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
| Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
| Q37329008 | Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development |
| Q34008159 | Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade |
| Q34241383 | Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer |
| Q98175461 | Pathway analysis of renal cell carcinoma genome-wide association studies identifies novel associations |
| Q31030138 | Pathway, in silico and tissue-specific expression quantitative analyses of oesophageal squamous cell carcinoma genome-wide association studies data |
| Q34378988 | Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors |
| Q24655318 | Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway |
| Q77614775 | Patterns of low-affinity immunoglobulin receptor polymorphisms in stroke and homozygous sickle cell disease |
| Q35839864 | Perforin gene mutations in patients with acquired aplastic anemia |
| Q34064069 | Performance of common genetic variants in breast-cancer risk models |
| Q24796958 | Performance of high-throughput DNA quantification methods |
| Q23910820 | Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies |
| Q33455775 | Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression |
| Q34587451 | Phred-Phrap package to analyses tools: a pipeline to facilitate population genetics re-sequencing studies |
| Q36831883 | Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q37570238 | Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q99609978 | Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast |
| Q44032172 | Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies |
| Q33322946 | Polymorphism Interaction Analysis (PIA): a method for investigating complex gene-gene interactions |
| Q33265968 | Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations |
| Q33891803 | Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium |
| Q36743879 | Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China |
| Q57250685 | Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses |
| Q24630661 | Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma |
| Q56994843 | Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut |
| Q34259663 | Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies |
| Q58419125 | Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia |
| Q24820920 | Polymorphisms in DNA repair genes and susceptibility to primary intracranial brain gliomas |
| Q37434877 | Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer |
| Q37515655 | Polymorphisms in DNA repair pathway genes, body mass index, and risk of non-Hodgkin lymphoma |
| Q34282820 | Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain |
| Q37721811 | Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma |
| Q53343406 | Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. |
| Q35612594 | Polymorphisms in Th1/Th2 cytokine genes, hormone replacement therapy, and risk of non-Hodgkin lymphoma |
| Q38333848 | Polymorphisms in XPD and TP53 and mutation in human lung cancer |
| Q45227004 | Polymorphisms in angiogenesis-related genes and prostate cancer |
| Q40185674 | Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults |
| Q36081383 | Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma |
| Q46757522 | Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among workers exposed to benzene |
| Q37090417 | Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer |
| Q46515714 | Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China |
| Q34577812 | Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth |
| Q58047420 | Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity |
| Q34024839 | Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. |
| Q58419133 | Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study |
| Q53565948 | Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. |
| Q33337513 | Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study |
| Q24645582 | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China |
| Q24618761 | Polymorphisms in innate immunity genes and risk of childhood leukemia |
| Q35596720 | Polymorphisms in integrin genes and lymphoma risk |
| Q57481340 | Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population |
| Q57568614 | Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer |
| Q44500715 | Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma |
| Q44096163 | Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma. |
| Q81625656 | Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China |
| Q81682241 | Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China |
| Q46879738 | Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies |
| Q24825190 | Polymorphisms in the estrogen metabolism genes CYP17, CYP1B1, CYP1A2, COMT and ER alpha and susceptibility to primary intracranial brain gliomas in women |
| Q34434293 | Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis. |
| Q33829203 | Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China |
| Q33964582 | Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China |
| Q36923979 | Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk |
| Q33733210 | Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer |
| Q33846878 | Population genetics and comparative genetics of CLDN1, a gene involved in hepatitis C virus entry |
| Q61445400 | Population structure of human gut bacteria in a diverse cohort from rural Tanzania and Botswana |
| Q33348644 | Population substructure and control selection in genome-wide association studies |
| Q34155371 | Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women |
| Q38720240 | Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes |
| Q34544433 | Powerful SNP-set analysis for case-control genome-wide association studies |
| Q92057675 | Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q37223335 | Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status |
| Q36040421 | Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models |
| Q58770866 | Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank |
| Q23917519 | Prevalence in the United States of selected candidate gene variants. Third National Health and Nutrition Examination Survey, 1991- 1994 |
| Q60934832 | Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls |
| Q36614790 | Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis |
| Q35839898 | Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival |
| Q37059182 | Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies |
| Q46506681 | Promoter composition predicts gene classes in microarray expression analyses of breast cancer |
| Q37641177 | Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts |
| Q81638679 | Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China |
| Q37103045 | Prostate Cancer Susceptibility in Men of African Ancestry at 8q24 |
| Q37735483 | Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q34688123 | Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence |
| Q94562441 | Protein-altering germline mutations implicate novel genes related to lung cancer development |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q64277598 | Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma |
| Q60909421 | Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q24656179 | Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3) |
| Q34425236 | RAD51B Activity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines |
| Q89049593 | Racial Disparities in Lung Cancer Survival: The Contribution of Stage, Treatment, and Ancestry |
| Q28394958 | Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma |
| Q47786373 | Rare germline variants in known melanoma susceptibility genes in familial melanoma |
| Q33751971 | Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma |
| Q28943461 | Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer |
| Q37341453 | Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q33835331 | Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. |
| Q37353536 | Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma |
| Q37322102 | Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms |
| Q29614919 | Replicating genotype-phenotype associations |
| Q35661241 | Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q90259542 | Reply to 'Mosaic loss of chromosome Y in leukocytes matters' |
| Q36245573 | Reproductive aging-associated common genetic variants and the risk of breast cancer |
| Q57611127 | Response |
| Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
| Q24601105 | Risk of meningioma and common variation in genes related to innate immunity |
| Q35849056 | Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes |
| Q34972303 | Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development |
| Q46926553 | Risk of small-for-gestational age is associated with common anti-inflammatory cytokine polymorphisms |
| Q51971587 | Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. |
| Q44174853 | Risk of testicular germ cell tumors and polymorphisms in the insulin-like growth factor genes |
| Q92153959 | Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study |
| Q37632617 | Role of one-carbon metabolizing pathway genes and gene-nutrient interaction in the risk of non-Hodgkin lymphoma |
| Q33404436 | SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
| Q34922555 | SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes |
| Q25257137 | SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes |
| Q28754873 | SNPs meet CNVs in genome-wide association studies: HGV2007 meeting report |
| Q44061474 | SNPs, haplotypes, and cancer: applications in molecular epidemiology. |
| Q34845811 | Scanning for clues to better use selective estrogen receptor modulators |
| Q36794423 | Scanning the horizon: what is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention? |
| Q46913654 | Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China |
| Q46609193 | Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis |
| Q37074059 | Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population |
| Q57271433 | Sequence Variants of Estrogen Receptor and Risk of Prostate Cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q33723482 | Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies |
| Q35728992 | Serum selenium and risk of prostate cancer-a nested case-control study |
| Q29417074 | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study |
| Q48548340 | Seventh international meeting on single nucleotide polymorphism and complex genome analysis: 'ever bigger scans and an increasingly variable genome'. |
| Q92969786 | Sex specific associations in genome wide association analysis of renal cell carcinoma |
| Q92151095 | Sex-Related Effect on Immunotherapy Response: Implications and Opportunities |
| Q56334258 | Sex-specific gene and pathway modeling of inherited glioma risk |
| Q54938714 | Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21. |
| Q34765317 | Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q36379200 | Sharing Clinical and Genomic Data on Cancer - The Need for Global Solutions |
| Q28660988 | Significant interactions between maternal PAH exposure and haplotypes in candidate genes on B[a]P-DNA adducts in a NYC cohort of non-smoking African-American and Dominican mothers and newborns |
| Q39449569 | Significant interactions between maternal PAH exposure and single nucleotide polymorphisms in candidate genes on B[ a ]P-DNA adducts in a cohort of non-smoking Polish mothers and newborns. |
| Q28730698 | Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer |
| Q37151786 | Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer |
| Q37120433 | Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma |
| Q23909513 | Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma |
| Q24646434 | Six new loci associated with body mass index highlight a neuronal influence on body weight regulation |
| Q43625208 | Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China |
| Q34368829 | Socioeconomic and nutritional factors account for the association of gastric cancer with Amerindian ancestry in a Latin American admixed population |
| Q36214274 | Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study. |
| Q35749438 | Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas |
| Q52774932 | Stem cells: Subclone wars. |
| Q92003869 | Stomaching Multigene Panel Testing: What to Do About CDH1? |
| Q44670482 | Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients |
| Q104691963 | Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia |
| Q52332078 | Subphenotype meta-analysis of testicular cancer genome-wide association study data suggests a role for RBFOX family genes in cryptorchidism susceptibility. |
| Q99408717 | Subsequent Neoplasm Risk Associated With Rare Variants in DNA Damage Response and Clinical Radiation Sensitivity Syndrome Genes in the Childhood Cancer Survivor Study |
| Q51580030 | Successful genome-wide scan in paired blood and buccal samples. |
| Q54980489 | Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays. |
| Q96166820 | Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI |
| Q59062123 | Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma |
| Q33755957 | Systems biology of human benzene exposure |
| Q28386653 | TERT gene harbors multiple variants associated with pancreatic cancer susceptibility |
| Q33563729 | TET2 binds the androgen receptor and loss is associated with prostate cancer |
| Q57568595 | TGFB1andTGFBR1polymorphic variants in relationship to bladder cancer risk and prognosis |
| Q58047341 | TNF polymorphisms and prostate cancer risk |
| Q31131061 | Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations |
| Q33992365 | Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts |
| Q58093702 | Telomere length-associated genetic variants and the risk of thyroid cancer in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS) |
| Q40411183 | Telomere stability genes are not mutated in osteosarcoma cell lines |
| Q28397509 | Telomere structure and maintenance gene variants and risk of five cancer types |
| Q34331070 | Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. |
| Q34372389 | The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease |
| Q28397565 | The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia |
| Q35746371 | The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer |
| Q54048444 | The DARC side of GWAS. |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q34673513 | The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study |
| Q34400153 | The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery |
| Q37578078 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers |
| Q34113976 | The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop |
| Q35638497 | The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies |
| Q30239099 | The ageing genome, clonal mosaicism and chronic disease |
| Q35166994 | The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study |
| Q35750240 | The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma |
| Q79838774 | The devil is in the DNA |
| Q33358043 | The etiology of childhood immune thrombocytopenic purpura: how complex is it? |
| Q36709437 | The future of pediatric cancer and complex diseases: aren't they all? |
| Q96576422 | The genomic and epigenomic evolutionary history of papillary renal cell carcinomas |
| Q60921979 | The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study |
| Q30428393 | The landscape of recombination in African Americans |
| Q28396374 | The long and short of telomeres and cancer association studies |
| Q46412035 | The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women |
| Q36042292 | The new sequencer on the block: comparison of Life Technology's Proton sequencer to an Illumina HiSeq for whole-exome sequencing |
| Q93358223 | The paradox of mutations and cancer |
| Q48052641 | The population genetics of Quechuas, the largest native South American group: autosomal sequences, SNPs, and microsatellites evidence high level of diversity |
| Q33686851 | The potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data |
| Q115779725 | The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer |
| Q53196885 | The riddle of intergenic disease-associated loci. |
| Q57423268 | The road ahead: less travelled and more arduous than initially envisioned |
| Q34151528 | Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies |
| Q29248193 | Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 |
| Q57272141 | Tobacco smoking,NAT2 acetylation genotype and breast cancer risk |
| Q36201193 | Toward mapping the biology of the genome |
| Q40520915 | Toxicological considerations in the application and interpretation of susceptibility biomarkers in epidemiological studies |
| Q114677146 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction |
| Q36559648 | Transcriptional networks inferred from molecular signatures of breast cancer |
| Q91311927 | Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q24289006 | Transforming Epidemiology for 21st Century Medicine and Public Health |
| Q53331345 | Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. |
| Q91889889 | Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women |
| Q33741481 | Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium |
| Q43051933 | Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. |
| Q57285472 | Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia |
| Q35575585 | Two susceptibility loci identified for prostate cancer aggressiveness |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q36151558 | Use of 'Omic' technologies to study humans exposed to benzene |
| Q34750497 | Using genetic variation to study immunomodulation |
| Q35829133 | Using germ-line genetic variation to investigate and treat cancer |
| Q33708556 | Using principal components of genetic variation for robust and powerful detection of gene-gene interactions in case-control and case-only studies |
| Q100560251 | Using whole-exome sequencing and protein interaction networks to prioritize candidate genes for germline cutaneous melanoma susceptibility |
| Q46439168 | Utilizing Fluidigm's Access Array Long-Range Capability and Roche 454 s Titanium Chemistry to Capture and Sequence the Epstein-Barr Virus (EBV) for Variant Detection |
| Q35032730 | Validation of genome-wide prostate cancer associations in men of African descent |
| Q53219234 | Validation of the performance of a comprehensive genotyping assay panel of single nucleotide polymorphisms in drug metabolism enzyme genes. |
| Q34422433 | Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium |
| Q53577666 | Variant in sex hormone-binding globulin gene and the risk of prostate cancer. |
| Q33759665 | Variants in blood pressure genes and the risk of renal cell carcinoma |
| Q37148025 | Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China |
| Q33814909 | Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China |
| Q37217280 | Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial |
| Q46881896 | Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease |
| Q33814993 | Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China |
| Q57481328 | Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma |
| Q57833833 | Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma |
| Q42725643 | Variation in KLK genes, prostate-specific antigen and risk of prostate cancer |
| Q28742972 | Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1 |
| Q34306330 | Variation in innate immunity genes and risk of multiple myeloma |
| Q34706603 | Variation in the SLC23A1 gene does not influence cardiometabolic outcomes to the extent expected given its association with L-ascorbic acid |
| Q46593244 | Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma |
| Q37280599 | Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma |
| Q33584179 | Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk |
| Q35989413 | Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita |
| Q66679149 | Viral coinfection analysis using a MinHash toolkit |
| Q40012482 | Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q33561895 | Vitamin D receptor polymorphisms and renal cancer risk in Central and Eastern Europe |
| Q37175504 | Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk |
| Q33557434 | Vitamin d pathway genes, diet, and risk of renal cell carcinoma |
| Q34055338 | Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors |
| Q59071759 | When the smoke clears .. |
| Q104464155 | White Blood Cell Count and Risk of Incident Lung Cancer in the UK Biobank |
| Q37686900 | Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes |
| Q37216463 | Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene |
| Q42733617 | Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility |
| Q51916590 | Whole genome amplification of buccal cytobrush DNA collected for molecular epidemiology studies. |
| Q34791432 | Widespread purifying selection at polymorphic sites in human protein-coding loci |
| Q28917124 | Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data |
| Q62089510 | Winners curse correction and variable thresholding improve performance of polygenic risk modeling based on summary-level data from genome-wide association studies |
| Q34636078 | Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma |
| Q58047271 | Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma |
| Stephen Chanock | wikipedia |
Search more.